SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $241,411,144 |
| Positions | 41 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| AXSOME THERAPEUTICS INC. | AXSM | COM | $158,796,006 | 648,756 |
| SPDR SERIES TRUST | BIL | ST STR BLO 1 ETF | $29,739,597 | 324,526 |
| KURA ONCOLOGY INC | KURA | COM | $23,782,280 | 2,167,938 |
| IMMUNEERING CORP | IMRX | CLASS A COM | $2,359,946 | 472,935 |
| ISHARES TR | TLT | 20 YR TR BD ETF | $1,838,672 | 21,276 |
| TEMPUS AI INC | TEM | CL A | $1,827,923 | 31,554 |
| VIATRIS INC | VTRS | COM | $1,244,738 | 78,384 |
| PHILIP MORRIS INTL INC | PM | COM | $1,236,339 | 6,834 |
| AUTOMATIC DATA PROCESSING IN | ADP | COM | $1,232,173 | 5,502 |
| WILLIAMS COS INC | WMB | COM | $1,137,476 | 15,301 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.